Publicaciones en colaboración con investigadores/as de Oslo University Hospital (7)

2023

  1. European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors

    International Journal of Gynecological Cancer, Vol. 33, Núm. 10, pp. 1621-1626

2019

  1. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: Pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    Obstetrical and Gynecological Survey

2018

  1. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    The Lancet Oncology, Vol. 19, Núm. 12, pp. 1680-1687

2011

  1. Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer

    Journal of Clinical Oncology

  2. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer

    European Journal of Cancer, Vol. 47, Núm. SUPPL. 3

2010

  1. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

    New England Journal of Medicine, Vol. 363, Núm. 10, pp. 943-953

2007

  1. Results of the 2006 Innsbruck International Consensus Conference on Intraperitoneal Chemotherapy in Patients with Ovarian Cancer

    Cancer